Global Task Force on Radiotherapy for Cancer Control

Affiliations

¹ Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, 610 University Avenue, M5G 2M9, Toronto, ON, Canada; TECHNA Institute, University Health Network, Toronto, ON, Canada.
² Harvard Global Equity Initiative, Harvard University, Cambridge, MA, USA; Harvard Medical School, Harvard University, Cambridge, MA, USA.
³ Harvard TH Chan School of Public Health, Harvard University, Cambridge, MA, USA.
⁴ Union for International Cancer Control, Geneva, Switzerland.
⁵ Ingham Institute for Applied Medical Research, University of New South Wales, Liverpool, NSW, Australia.
⁶ Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
⁷ Ghent University Hospital, Ghent, Belgium; Ghent University, Ghent, Belgium.
⁸ TECHNA Institute, University Health Network, Toronto, ON, Canada.
⁹ Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
¹⁰ International Atomic Energy Agency, Vienna, Austria.
¹¹ Department of Medical Biophysics, Western University, London, ON, Canada.
¹² National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
¹³ Princess Margaret Cancer Centre, 610 University Avenue, M5G 2M9, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. Electronic address: Mary.Gospodarowicz@rmp.uhn.on.ca.

Comment

David A Jaffray et al. Lancet Oncol. 2015 Sep.

. 2015 Sep;16(10):1144-6.

doi: 10.1016/S1470-2045(15)00285-5.

¹ Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, 610 University Avenue, M5G 2M9, Toronto, ON, Canada; TECHNA Institute, University Health Network, Toronto, ON, Canada.
² Harvard Global Equity Initiative, Harvard University, Cambridge, MA, USA; Harvard Medical School, Harvard University, Cambridge, MA, USA.
³ Harvard TH Chan School of Public Health, Harvard University, Cambridge, MA, USA.
⁴ Union for International Cancer Control, Geneva, Switzerland.
⁵ Ingham Institute for Applied Medical Research, University of New South Wales, Liverpool, NSW, Australia.
⁶ Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
⁷ Ghent University Hospital, Ghent, Belgium; Ghent University, Ghent, Belgium.
⁸ TECHNA Institute, University Health Network, Toronto, ON, Canada.
⁹ Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
¹⁰ International Atomic Energy Agency, Vienna, Austria.
¹¹ Department of Medical Biophysics, Western University, London, ON, Canada.
¹² National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
¹³ Princess Margaret Cancer Centre, 610 University Avenue, M5G 2M9, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. Electronic address: Mary.Gospodarowicz@rmp.uhn.on.ca.

No abstract available

Comment on

Expanding global access to radiotherapy.
Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O'Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M. Atun R, et al. Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3. Lancet Oncol. 2015. PMID: 26419354 Review.